Skip to main
BLCM
BLCM logo

Bellicum Pharmaceuticals (BLCM) Earnings Dates & Reports

Bellicum Pharmaceuticals (BLCM) Most Recent Earnings

Report DateMar 31, 2023
Period EndingQ4 2022
Est. EPS-$0.93
Actual EPS-$0.20
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Bellicum Pharmaceuticals (BLCM) Earnings per Share (EPS) History

Signup for full access
Browse free

Bellicum Pharmaceuticals (BLCM) Latest Earnings

The value each BLCM share was expected to gain vs. the value each share gained.

Bellicum Pharmaceuticals (BLCM) reported its most recent earnings on Mar 31, 2023 for Q4 2022, posting earnings per share (EPS) of -$0.20. This exceeded analysts' expectations of -$0.93 by 78.49%, marking a Beat.

For comparison, Bellicum Pharmaceuticals reported EPS of $0.11 in the same quarter last year.

The company is expected to announce its next earnings report on 11/14/2023, with analysts projecting an EPS of $0.

Bellicum Pharmaceuticals (BLCM) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2023Nov 14, 2023
-$0.02
DeckReportListen
Q2 2023Aug 10, 2023
-$0.24
Q1 2023May 11, 2023
-$0.26
Q4 2022Mar 31, 2023
-$0.93-$0.20-78.49%
Q3 2022Nov 10, 2022
-$0.64-$0.23-64.06%
View all

Bellicum Pharmaceuticals (BLCM) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Bellicum Pharmaceuticals’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 10, 2023
May 11, 2023
Mar 31, 2023
Nov 10, 2022

Bellicum Pharmaceuticals (BLCM) Earnings FAQs

Bellicum Pharmaceuticals (BLCM) last reported earnings on Mar 31, 2023 for Q4 2022, posting an EPS of -$0.20, which Beat the estimate of -$0.93 by 78.49%.

For Q4 2022, Bellicum Pharmaceuticals (BLCM) reported an EPS of -$0.20, exceeding analysts' estimate of -$0.93 by 78.49%.

For Q4 2022, Bellicum Pharmaceuticals (BLCM) Beat expectations with an actual EPS of -$0.20 vs. an estimated EPS of -$0.93.

Following the last earnings report on Mar 31, 2023, Bellicum Pharmaceuticals (BLCM)'s stock price moved — from — to —.

The next Bellicum Pharmaceuticals (BLCM) earnings call is scheduled for Nov. 14, 2023, where executives will discuss financial results and outlook.

Bellicum Pharmaceuticals (BLCM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.